Physician profile
Elizabeth E Holmes
NPI 1558856807
$1,494.80
in general payments reported to CMS, 2019-2025
13 companies · $351 in 2025
The $351 reported for 2025 was more than what a typical Acute Care (Nurse Practitioner) provider received nationally (typical 2025 total: $151).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $90.87 · 2022: $537 · 2023: $314 · 2024: $202 · 2025: $351.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $867.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $867.10 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $168.07 | 2021-2022 | |
| Stryker Corporation | $148.78 | 2025 | Flowtriever, Inthrill Thrombectomy Catheter |
| Boston Scientific Corporation | $145.86 | 2023-2025 | Eluvia, Watchman, Ekosonic |
| Eagle Pharmaceuticals, INC. | $137.19 | 2023 | |
| Medtronic, INC. | $128.24 | 2025 | Interstim, Heli-Fx Endoanchor System |
| Janssen Pharmaceuticals, INC | $125.54 | 2023-2024 | Xarelto |
| Biohaven Pharmaceutical Holding Company LTD. | $125.00 | 2022 | |
| Abiomed | $124.95 | 2024 | Impella |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $124.71 | 2022 | |
| Astrazeneca Pharmaceuticals LP | $118.40 | 2022 | |
| Abbvie INC. | $71.74 | 2022 | |
| Medline Industries LP | $56.54 | 2025 | |
| Aesculap, INC. | $19.78 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Elizabeth Holmes listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.